The initiating biochemical reaction is the non-covalent binding of the drug, or its metabolite, to a specific Human Leukocyte Antigen (HLA) molecule. This forms a complex that is recognized as foreign by T-cell receptors, triggering a cytotoxic immune cascade against the patient's own skin cells.